Related references
Note: Only part of the references are listed.Protective efficacy of a peptide derived from a potential adhesin of Pseudomonas aeruginosa against corneal infection
Qing Yuan et al.
EXPERIMENTAL EYE RESEARCH (2016)
Antibodies from the sera of HIV-infected patients efficiently hydrolyze all human histones
Svetlana V. Baranova et al.
JOURNAL OF MOLECULAR RECOGNITION (2016)
Renin gene rs1464816 polymorphism contributes to chronic kidney disease progression in ADPKD
Gnanasambandan Ramanathan et al.
JOURNAL OF BIOMEDICAL SCIENCE (2016)
Bispecific antibodies
Roland E. Kontermann et al.
DRUG DISCOVERY TODAY (2015)
Peptide therapeutics: current status and future directions
Keld Fosgerau et al.
DRUG DISCOVERY TODAY (2015)
Advances in phage display technology for drug discovery
Kobra Omidfar et al.
EXPERT OPINION ON DRUG DISCOVERY (2015)
Alternative molecular formats and therapeutic applications for bispecific antibodies
Christoph Spiess et al.
MOLECULAR IMMUNOLOGY (2015)
Use of Phage Display technology in development of canine visceral leishmaniasis vaccine using synthetic peptide trapped in sphingomyelin/cholesterol liposomes
Christina Monerat Toledo-Machado et al.
PARASITES & VECTORS (2015)
Theranostic applications of phage display to control leishmaniasis: selection of biomarkers for serodiagnostics, vaccination, and immunotherapy
Eduardo Antonio Ferraz Coelho et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2015)
MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial
Frank Behrens et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Catalytic antibodies and their applications in biotechnology: state of the art
Severine Padiolleau-Lefevre et al.
BIOTECHNOLOGY LETTERS (2014)
A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma
Ghassan K. Abou-Alfa et al.
JOURNAL OF HEPATOLOGY (2014)
Pharmacokinetics of Peptide-Fc Fusion Proteins
Benjamin Wu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma
John C. Morris et al.
PLOS ONE (2014)
Mimotope-Based Vaccines of Leishmania infantum Antigens and Their Protective Efficacy against Visceral Leishmaniasis
Lourena Emanuele Costa et al.
PLOS ONE (2014)
Raxibacumab: potential role in the treatment of inhalational anthrax
Carlos E. Kummerfeldt
INFECTION AND DRUG RESISTANCE (2014)
Identification and evaluation of a novel peptide binding to the cell surface of Staphylococcus aureus
Shilpakala Sainath Rao et al.
MICROBIOLOGICAL RESEARCH (2013)
A tale of two specificities: bispecific antibodies for therapeutic and diagnostic applications
Hannah Byrne et al.
TRENDS IN BIOTECHNOLOGY (2013)
Development of Anti-Infectives Using Phage Display: Biological Agents against Bacteria, Viruses, and Parasites
Johnny X. Huang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Biocatalysts: Beautiful creatures
Walid Saibi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Monoclonal antibody therapeutics: history and future
Nicholas A. P. S. Buss et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
Antibody Phage Display Libraries: Contributions to Oncology
Carmela Dantas-Barbosa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Agonism and Antagonism at the Insulin Receptor
Louise Knudsen et al.
PLOS ONE (2012)
Bacteriophages and their implications on future biotechnology: a review
Irshad Ul Haq et al.
VIROLOGY JOURNAL (2012)
Monoclonal antibodies against β-amyloid (Aβ) for the treatment of Alzheimer's disease: the Aβ target at a crossroads
Francesco Panza et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2011)
Peptide mimics of peptidoglycan are vaccine candidates and protect mice from infection with Staphylococcus aureus
Yiguo Chen et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2011)
High Affinity, Developability and Functional Size: The Holy Grail of Combinatorial Antibody Library Generation
Dirk Ponsel et al.
MOLECULES (2011)
Anti-virulence strategies to combat bacteria-mediated disease
David A. Rasko et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Safety, Pharmacokinetics, and Antitumor Activity of AMG 386, a Selective Angiopoietin Inhibitor, in Adult Patients With Advanced Solid Tumors
Roy S. Herbst et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Quality specifications for peptide drugs: a regulatory-pharmaceutical approach
Valentijn Vergote et al.
JOURNAL OF PEPTIDE SCIENCE (2009)
Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site
Jenny Bostrom et al.
SCIENCE (2009)
Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis
Alexa B. Kimball et al.
ARCHIVES OF DERMATOLOGY (2008)
Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer
F. Anthony Greco et al.
LUNG CANCER (2008)
Cell-division inhibitors: new insights for future antibiotics
Rowena L. Lock et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Catalytic antibody degradation of ghrelin increases whole-body metabolic rate and reduces refeeding in fasting mice
Alexander V. Mayorov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin
Larisa L. Belyanskaya et al.
MOLECULAR CANCER (2007)
Microbiology of antibiotic resistance in Staphylococcus aureus
Peter C. Appelbaum
CLINICAL INFECTIOUS DISEASES (2007)
Invasive Pseudomonas aeruginosa infections:: high rate of recurrence and mortality after hematopoietic cell transplantation
M. Hakki et al.
BONE MARROW TRANSPLANTATION (2007)
Identification and characterization of single chain anti-cocaine catalytic antibodies
Kathleen M. McKenzie et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
A peptide inhibitor of MurA UDP-N-acetylglucosamine enolpyruvyl transferase:: The first committed step in peptidoglycan biosynthesis
Jose Molina-Lopez et al.
PEPTIDES (2006)
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP
James B. Bussel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Is the oral route possible for peptide and protein drug delivery
Mariko Morishita et al.
DRUG DISCOVERY TODAY (2006)
Targeting antibacterial agents by using drug-carrying filamentous bacteriophages
Iftach Yacoby et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
A novel peptide isolated from phage library to substitute a complex system for a vaccine against staphylococci infection
G Yang et al.
VACCINE (2006)
Inhibition of human interleukin-13-induced respiratory and oesophageal inflammation by anti-human-interleukin-13 antibody (CAT-354)
C Blanchard et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2005)
Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity
RM Hoet et al.
NATURE BIOTECHNOLOGY (2005)
Use of phage display to identify potential Pseudomonas aeruginosa gene products relevant to early cystic fibrosis airway infections
C Beckmann et al.
INFECTION AND IMMUNITY (2005)
The remarkable flexibility of the human antibody repertoire; Isolation of over one thousand different antibodies to a single protein, BLyS
BM Edwards et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Phage display as a tool for the directed evolution of enzymes
A Fernandez-Gacio et al.
TRENDS IN BIOTECHNOLOGY (2003)
Antibody proteases: Induction of catalytic response
AG Gabibov et al.
BIOCHEMISTRY-MOSCOW (2002)
Filamentous phage integration requires the host recombinases XerC and XerD
KE Huber et al.
NATURE (2002)
Vaccination against Helicobacter pylori -: an old companion of man
WCF Keller et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2001)
Selection of human single chain Fv antibody fragments binding and inhibiting Helicobacter pylori urease
M Houimel et al.
TUMOR BIOLOGY (2001)
The phage infection process: A functional role for the distal linker region of bacteriophage protein 3
N Nilsson et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
